These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8803657)

  • 1. Pharmacological treatment strategies in acute schizophrenia.
    Marder SR
    Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():29-34. PubMed ID: 8803657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.
    Bradford DW; Perkins DO; Lieberman JA
    Drugs; 2003; 63(21):2265-83. PubMed ID: 14524730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological strategies for the management of comorbid depression and schizophrenia.
    Ceskova E
    Expert Opin Pharmacother; 2020 Mar; 21(4):459-465. PubMed ID: 31983254
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipsychotic drugs and relapse prevention.
    Marder SR
    Schizophr Res; 1999 Mar; 35 Suppl():S87-92. PubMed ID: 10190229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy review of antipsychotics.
    Krausz M
    Curr Med Res Opin; 2002; 18 Suppl 3():s8-12. PubMed ID: 12418606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of schizophrenia].
    Kovacs G
    Neuropsychopharmacol Hung; 2011 Dec; 13(4):239-47. PubMed ID: 22184193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of long-acting antipsychotic medication in patient care.
    Kane JM
    CNS Spectr; 2006 Dec; 11(12 Suppl 14):1-7; quiz 7-8. PubMed ID: 17146411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of the antipsychotics.
    Kessler KA; Waletzky JP
    Am J Psychiatry; 1981 Feb; 138(2):202-9. PubMed ID: 6109455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of treatment-resistant patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of atypical antipsychotic drugs.
    Grundmann M; Kacirova I; Urinovska R
    Acta Pharm; 2014 Dec; 64(4):387-401. PubMed ID: 25531781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological approaches to the management of schizophrenia: 10 years on.
    Castle D; Keks N; Newton R; Schweitzer I; Copolov D; Paoletti N; Burrows G; Tiller J
    Australas Psychiatry; 2013 Aug; 21(4):329-34. PubMed ID: 23616381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
    Leucht S; Leucht C; Huhn M; Chaimani A; Mavridis D; Helfer B; Samara M; Rabaioli M; Bächer S; Cipriani A; Geddes JR; Salanti G; Davis JM
    Am J Psychiatry; 2017 Oct; 174(10):927-942. PubMed ID: 28541090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.